colitis: Inflammation of the colon.
Colitis, primary sclerosing, strict definition
DOID EFO Endpoint Browser PheWeb
K11_PSC_COLITIS_STRICT
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
2381 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
389 |
6. Filter based on genotype QC (FinnGen only) |
389 |
Control definitions (FinnGen only)
- Control conditions
- not K11_CHOLANGI
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF3
Similar endpoints
↥List of similar endpoints to
Colitis, primary sclerosing, strict definition
based on the number of shared cases.
Similar with more cases:
- Colitis, primary sclerosing
- Cholangitis (primary sclerosing, PSC)
- Mucosal proctocolitis
- Ulcerative colitis
- Inflammatory bowel disease
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1356 | 487 | 865 |
| Only index persons | 1293 | 469 | 824 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.01 | 0.02 |
| Only index persons | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 36.00 | 36.74 | 35.48 |
| Only index persons | 35.04 | 36.02 | 34.48 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 389 | 174 | 215 |
| Unadjusted period prevalence (%) | 0.08 | 0.06 | 0.09 |
| Median age at first event (years) | 37.81 | 37.94 | 37.70 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 360
- Matched controls
- 3597
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K51.5
ICD-10 Finland
Left sided colitis
12302.2
323.0
359
54
A05AA02
ATC
ursodeoxycholic acid; oral
1052.2
323.0
308
20
A07EC02
ATC
mesalazine; oral, rectal
513.0
323.0
338
104
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
622.5
323.0
340
95
K83.0
ICD-10 Finland
Cholangitis
+∞
323.0
358
*
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
1087.5
289.5
246
7
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
152.6
254.5
255
56
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
52.9
205.0
265
180
UJF32
NOMESCO Finland
Coloscopy
40.9
189.4
300
392
UJF30
NOMESCO Finland
Ileoscopy through colon
39.3
171.1
232
158
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
281.4
144.7
139
8
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
188.2
132.9
132
11
L04AX01
ATC
azathioprine; systemic
45.2
132.7
165
66
K51.8
ICD-10 Finland
Other ulcerative colitis
129.2
127.9
132
16
UJK02
NOMESCO Finland
ERCP
98.5
127.3
136
22
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
26.4
119.9
177
127
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
79.5
119.6
132
26
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
79.8
116.9
129
25
WX404
NOMESCO Finland
Intravenous generell anesthesy
13.4
102.5
224
394
A07EA06
ATC
budesonide; oral, local oral
29.9
90.3
124
62
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
103.8
87.1
93
12
WX402
NOMESCO Finland
General anaesthesia
11.2
82.6
187
317
UJK12
NOMESCO Finland
Peroral cholangioscopy
+∞
82.5
76
*
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
138.5
82.1
85
8
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
9.4
79.7
215
488
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
96.0
75.9
82
11
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
48.6
66.4
80
21
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.7
63.6
189
453
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
34.4
63.6
83
31
P01AB01
ATC
metronidazole; oral, rectal
6.8
62.3
246
864
A07EA02
ATC
hydrocortisone; rectal
27.5
57.7
80
37
J01MA12
ATC
levofloxacin; systemic
8.5
57.6
146
267
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
76.0
56.4
63
10
H02AB06
ATC
prednisolone; systemic
6.1
54.8
255
1027
K83.1
ICD-10 Finland
Obstruction of bile duct
114.9
54.7
58
6
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
+∞
54.6
51
*
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
68.7
46.8
53
9
WX002
NOMESCO Finland
Sedation and analgesia
6.4
45.8
144
339
J01MA02
ATC
ciprofloxacin; systemic
5.0
43.9
204
747
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
170.8
43.9
45
*
H02AB07
ATC
prednisone; oral
7.4
43.7
117
219
Z94.4
ICD-10 Finland
Liver transplant status
470.3
43.1
42
*
ZX120
NOMESCO Finland
Intravenous
8.8
43.0
100
150
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
7.0
42.9
121
243
K50.9
ICD-10 Finland
Crohn disease, unspecified
35.8
42.9
55
18
TPH04
NOMESCO Finland
Cathetrisation of vein
6.0
42.6
141
349
K50.8
ICD-10 Finland
Other Crohn disease
25.9
42.2
59
27
JJC00
NOMESCO Finland
Allogenic transplantation of liver
+∞
41.5
39
*
K51
ICD-10 Finland
Ulcerative colitis
39.3
38.3
48
14
K76.9
ICD-10 Finland
Liver disease, unspecified
36.7
37.7
48
15
K50.1
ICD-10 Finland
Crohn disease of large intestine
32.3
36.6
48
17
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
141.1
36.5
38
*
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
141.1
36.5
38
*
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
84.4
34.6
38
5
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
102.8
34.4
37
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
11.6
34.4
66
68
K74.3
ICD-10 Finland
Primary biliary cirrhosis
68.4
32.7
37
6
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
7.8
32.5
80
127
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
96.7
32.4
35
*
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
181.1
32.3
33
*
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
+∞
31.7
30
*
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
+∞
30.7
29
*
K80.3
ICD-10 Finland
Calculus of bile duct with cholangitis
328.6
30.3
30
*
127
Kela drug reimbursment
Transplant complication
33.4
30.1
39
13
L04AD01
ATC
ciclosporin; systemic
25.5
29.5
41
18
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
30.1
28.6
38
14
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
46.8
28.3
34
8
L01BB02
ATC
mercaptopurine; oral
28.2
28.1
38
15
A07EC01
ATC
sulfasalazine; oral, rectal
6.5
27.8
78
147
5761C
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]
+∞
27.4
26
*
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
+∞
27.4
26
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
+∞
26.4
25
*
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
145.5
26.0
27
*
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
48.3
26.0
31
7
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.8
25.2
77
161
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
72.7
24.2
27
*
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
16.8
23.9
38
25
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.6
23.5
49
58
JJ5AT
NOMESCO Finland
NA
+∞
23.2
22
*
K50.0
ICD-10 Finland
Crohn disease of small intestine
15.0
22.9
38
28
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
23.3
22.6
32
15
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.6
22.5
50
66
R50.9
ICD-10 Finland
Fever, unspecified
4.4
22.1
90
255
H02AB04
ATC
methylprednisolone; systemic
4.7
22.1
83
217
5568X
ICD-9 Finland
Idiopathic proctocolitis, Other ulcerative colitis
85.6
21.9
24
*
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
11.4
21.8
41
40
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.1
21.6
174
843
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
53.5
21.4
25
5
JN4CD
NOMESCO Finland
Very extensive body CT
10.9
21.2
41
42
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
222.3
20.8
21
*
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
51.2
20.4
24
5
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
13.2
20.0
35
29
WX408
NOMESCO Finland
General anesthesy, balanced
3.2
19.9
135
572
L04AA06
ATC
mycophenolic acid; systemic
19.1
19.9
30
17
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
4.3
19.5
79
220
A07EA01
ATC
prednisolone; rectal
36.6
19.1
24
7
WX419
NOMESCO Finland
Other general anesthesy
29.7
19.0
25
9
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
8.7
18.4
40
51
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
17.7
18.2
28
17
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
19.3
18.1
27
15
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
28.4
18.1
24
9
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
9.5
17.9
37
43
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
+∞
17.9
17
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
8.2
17.7
40
54
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
12.9
17.7
31
26
JN1CM
NOMESCO Finland
Upper part of abdomen extensive MRI examination with 3 Tesla magnet
188.9
17.7
18
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.8
17.6
162
823
3AC01
NOMESCO Finland
NA
20.6
17.1
25
13
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
16.1
16.9
27
18
L04AA01
ATC
[U] ciclosporin; systemic
19.1
16.7
25
14
K85.8
ICD-10 Finland
Other acute pancreatitis
42.2
16.5
20
5
K80.5
ICD-10 Finland
Calculus of bile duct without cholangitis or cholecystitis
14.5
16.3
27
20
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
6.6
16.0
42
71
D94
ICPC
Chronic enteritis/ulcerative colitis
27.7
15.8
21
8
R10.1
ICD-10 Finland
Pain localized to upper abdomen
3.5
15.6
81
277
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
33.3
15.0
19
6
1370
FHL
Colonoscopy, whole colon
83.6
14.7
16
*
N02AX02
ATC
tramadol; systemic, rectal
2.5
14.7
166
920
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
9.8
14.5
29
32
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
6.9
14.4
36
57
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
20.2
14.4
21
11
JN3AD
NOMESCO Finland
Abdominal CT examination
5.1
14.0
45
98
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.0
13.8
88
347
UJF02
NOMESCO Finland
Peroral enteroscopy
26.9
13.5
18
7
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.6
13.4
48
117
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.4
13.4
50
127
C10AC01
ATC
colestyramine; oral
9.9
13.2
26
28
UJF92
NOMESCO Finland
Capsular endoscopy
9.0
13.0
27
32
Z93.2
ICD-10 Finland
Ileostomy status
72.5
12.7
14
*
L04AB04
ATC
adalimumab; parenteral
8.4
12.1
26
33
L04AC05
ATC
ustekinumab; parenteral
48.4
12.0
14
*
JL5AM
NOMESCO Finland
Bile and pancreas ducts simple MRI examination with 3 Tesla magnet
+∞
11.5
11
*
K83.3
ICD-10 Finland
Fistula of bile duct
+∞
11.5
11
*
JN1DM
NOMESCO Finland
Upper part of abdomen very extensive MRI examination with 3 Tesla magnet
+∞
11.5
11
*
A07AA11
ATC
rifaximin; oral
+∞
11.5
11
*
C22.1
ICD-10 Finland
Malignant neoplasm: Intrahepatic bile duct carcinoma
123.8
11.5
12
*
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
8.8
11.5
24
29
JFH33
NOMESCO Finland
Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy
36.3
11.3
14
*
A02BC02
ATC
pantoprazole; systemic
2.2
11.3
224
1553
WVA20
NOMESCO Finland
Medicine administration
9.0
11.2
23
27
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.0
11.0
44
120
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
9.3
10.9
22
25
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
4.8
10.8
36
82
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
8.1
10.6
23
30
A07DA03
ATC
loperamide; oral
7.5
10.5
24
34
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
33.6
10.4
13
*
JFF10
NOMESCO Finland
Loop enterostomy
33.6
10.4
13
*
JKA20
NOMESCO Finland
Cholecystectomy
13.7
10.3
17
13
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
13.7
10.3
17
13
TK800
NOMESCO Finland
Hemodialysis
8.8
10.2
21
25
H02AB09
ATC
hydrocortisone; systemic
8.5
10.0
21
26
JAH00
NOMESCO Finland
Laparotomy
8.2
9.8
21
27
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
56.6
9.7
11
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
4.2
9.6
36
93
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.8
9.5
31
69
A07AA09
ATC
vancomycin; oral
18.1
9.5
14
8
JK3BT
NOMESCO Finland
Catherisation of bile duct with X-ray guidance
102.6
9.5
10
*
3042
Kela drug reimbursment
NA
+∞
9.4
9
*
K83
ICD-10 Finland
Other diseases of biliary tract
+∞
9.4
9
*
JL5BM
NOMESCO Finland
Bile and pancreas ducts MRI examination with 3 Tesla magnet
+∞
9.4
9
*
253
Kela drug reimbursment
NA
+∞
9.4
9
*
R4110
NOMESCO Finland
Physiotherapy
2.3
9.2
104
550
A02BC01
ATC
omeprazole; systemic
2.3
9.1
94
475
D64.9
ICD-10 Finland
Anaemia, unspecified
3.8
9.1
38
108
K92.1
ICD-10 Finland
Melaena
5.1
9.1
28
59
JN4BD
NOMESCO Finland
Extensive body CT
3.5
8.9
41
126
K85
ICD-10 Finland
Acute pancreatitis
7.5
8.9
20
28
JFH10
NOMESCO Finland
Total colectomy and ileostomy
28.3
8.5
11
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
28.3
8.5
11
*
4AA12
NOMESCO Finland
NA
20.6
8.5
12
6
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.1
8.5
124
730
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
92.1
8.4
9
*
JK3SB
NOMESCO Finland
Endoscopic retrorade cholangiography
92.1
8.4
9
*
JFF13
NOMESCO Finland
Terminal enterostomy
92.1
8.4
9
*
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
13.2
8.4
14
11
56399
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Other
+∞
8.4
8
*
TJK00
NOMESCO Finland
Intraoperative cholangiography
+∞
8.4
8
*
4AA33
NOMESCO Finland
NA
+∞
8.4
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.2
8.3
43
146
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
7.1
8.2
19
28
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
12.1
8.1
14
12
K90.0
ICD-10 Finland
Coeliac disease
6.6
8.1
20
32
4AB02
NOMESCO Finland
NA
34.2
8.1
10
*
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
34.2
8.1
10
*
B01AB05
ATC
enoxaparin; parenteral
2.2
8.1
95
507
XX3DW
NOMESCO Finland
Time consuming IT work
3.2
8.0
42
144
JKE12
NOMESCO Finland
Endoscopic extraction of calculus from bile duct
13.4
7.9
13
10
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.2
7.9
18
26
M81.9
ICD-10 Finland
Osteoporosis, unspecified
11.1
7.9
14
13
XF400
NOMESCO Finland
ECG with 12 standard connections
2.5
7.8
62
274
ZJX00
NOMESCO Finland
Double balloon technique in gastroenterological endoscopy
46.0
7.7
9
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
46.0
7.7
9
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
18.8
7.6
11
6
A06AC01
ATC
ispaghula (psylla seeds); oral
2.3
7.4
75
374
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
11.2
7.4
13
12
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
3.6
7.4
32
95
5761A
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SUPPURATIVA]
+∞
7.3
7
*
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
+∞
7.3
7
*
JJC60
NOMESCO Finland
Total excision of transplanted liver
+∞
7.3
7
*
K83.4
ICD-10 Finland
Spasm of sphincter of Oddi
+∞
7.3
7
*
K74.5
ICD-10 Finland
Biliary cirrhosis, unspecified
+∞
7.3
7
*
WX892
NOMESCO Finland
Monitored bed care
3.5
7.2
33
102
K56.0
ICD-10 Finland
Paralytic ileus
30.7
7.2
9
*
R93.2
ICD-10 Finland
Abnormal findings on diagnostic imaging of liver and biliary tract
30.7
7.2
9
*
M05BA04
ATC
alendronic acid; oral
4.9
7.2
22
47
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.6
7.1
54
231
UJG02
NOMESCO Finland
Proctoscopy
7.2
7.1
16
23
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.4
7.1
60
275
Z01.8
ICD-10 Finland
Other specified special examinations
2.2
7.0
78
404
K85.0
ICD-10 Finland
Idiopathic acute pancreatitis
11.2
6.8
12
11
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
11.2
6.8
12
11
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
9.6
6.8
13
14
M07.5
ICD-10 Finland
Arthropathy in ulcerative colitis
40.8
6.8
8
*
H26.3
ICD-10 Finland
Drug-induced cataract
40.8
6.8
8
*
R4190
NOMESCO Finland
Nutritional therapy
4.6
6.8
22
50
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
17.1
6.8
10
6
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.4
6.7
31
97
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.8
6.7
21
46
K81.9
ICD-10 Finland
Cholecystitis, unspecified
23.0
6.7
9
*
R17
ICD-10 Finland
Hyperbilirubinaemia, with or without jaundice, not elsewhere classified
8.0
6.7
14
18
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
8.9
6.6
13
15
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.6
6.5
14
19
K51.4
ICD-10 Finland
Inflammatory polyps
71.1
6.4
7
*
5560A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis
71.1
6.4
7
*
UJD02
NOMESCO Finland
Gastroscopy
4.4
6.4
22
53
M81.8
ICD-10 Finland
Other osteoporosis
18.4
6.3
9
5
ZXC86
NOMESCO Finland
Use of endoscopic device
18.4
6.3
9
5
JK3FT
NOMESCO Finland
Exchange of bile duct catheter with radiological guidance
+∞
6.3
6
*
K83.2
ICD-10 Finland
Perforation of bile duct
+∞
6.3
6
*
C24.9
ICD-10 Finland
Malignant neoplasm: Biliary tract, unspecified
+∞
6.3
6
*
RS122
NOMESCO Finland
NA
+∞
6.3
6
*
A07EC03
ATC
olsalazine; oral
+∞
6.3
6
*
JFG73
NOMESCO Finland
Excision of ileal pelvic pouch
+∞
6.3
6
*
JFH11
NOMESCO Finland
Laparoscopic colectomy
+∞
6.3
6
*
XW000
NOMESCO Finland
Bone marrow biopsy
4.6
6.3
20
45
WX004
NOMESCO Finland
Patient-controlled sedation
27.2
6.3
8
*
K75.4
ICD-10 Finland
Autoimmune hepatitis
27.2
6.3
8
*
ZX108
NOMESCO Finland
Inhalation
27.2
6.3
8
*
C03DA01
ATC
spironolactone; oral
3.1
6.2
33
115
WW500
NOMESCO Finland
Blood transfusion
4.8
6.2
19
41
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
7.9
6.2
13
17
E86
ICD-10 Finland
Volume depletion
6.9
6.1
14
21
WZC30
NOMESCO Finland
Teaching
2.5
6.1
48
210
A04AA02
ATC
granisetron; systemic, transdermal
3.9
6.0
23
62
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
159
16
167.38
319.97
1.9
1.3
umol/l
11.2
10.7
0.21
159
16
(3024980) IgG subclass 4 [Mass/volume] in Serum
225
61
86.12
307.65
3.1
1.3
g/l
0.9
0.6
1.17
211
48
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
232
18
317.87
307.65
2.7
1.1
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
294
84
140.22
307.65
7.7
3.0
u/ml
38.5
1700.7
0.50
274
71
(3007566) Smooth muscle Ab [Titer] in Serum
257
96
76.95
307.65
3.0
1.1
titre
69.0
61.3
—
29
8
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
223
34
152.35
307.65
2.9
1.0
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
253
97
72.74
307.65
2.9
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
320
214
79.66
307.65
8.4
4.5
ug/l
2.5
27.1
0.65
259
174
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
163
30
92.80
301.23
1.9
1.1
titre
197.0
—
—
10
0
(3005719) IgG [Mass/volume] in Serum or Plasma
276
246
36.18
299.80
4.4
2.1
g/l
12.8
10.0
17.88
265
228
(3028026) IgM [Mass/volume] in Serum or Plasma
256
200
35.51
297.14
3.5
1.5
g/l
1.2
1.2
0.03
250
188
(3022145) Colonoscopy Study observation
300
316
38.12
297.10
3.6
1.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
332
445
45.09
282.83
7.1
2.2
ug/g
192.5
105.8
4.76
316
352
(40768441) Liver Pathology biopsy report
111
20
77.26
202.70
2.3
1.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
271
446
17.73
187.14
3.1
1.3
titre
459.8
408.7
0.19
107
92
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
241
351
16.42
181.07
12.1
2.1
umol/l
8.3
8.2
0.03
230
307
(3033658) Prothrombin time (PT) actual/Normal
312
744
17.13
154.93
18.2
3.6
%
96.8
93.7
1.40
307
730
(3032080) INR in Blood by Coagulation assay
343
960
22.76
147.05
19.1
6.4
inr
1.1
1.2
2.51
120
310
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
351
1109
23.16
131.04
16.7
3.1
u/l
36.7
31.8
3.07
344
1067
(3042936) Bacteria identified in Isolate by Culture
210
389
10.56
124.08
2.8
2.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
97
61
20.85
117.95
6.3
5.2
iu/ml
858.2
542.2
—
18
10
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
183
318
9.98
112.87
3.0
2.4
%
22.2
24.9
1.23
171
277
(42870588) Differential panel, method unspecified - Blood
313
977
12.28
112.59
14.8
5.8
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
138
171
11.96
111.16
2.5
1.5
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
263
692
9.65
110.76
3.6
1.3
g/l
2.5
2.3
1.69
251
451
(3004789) Transferrin [Mass/volume] in Serum or Plasma
182
342
9.12
103.83
3.0
2.3
g/l
2.5
2.4
0.09
174
319
(3022948) Iron [Moles/volume] in Serum or Plasma
186
378
8.51
98.10
3.1
2.3
umol/l
12.6
14.4
2.18
179
350
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
51
12
48.76
86.25
4.8
1.9
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
53
17
35.94
82.61
1.2
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
52
17
35.15
80.55
1.2
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
52
17
35.15
80.55
1.2
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
260
862
7.08
80.12
4.3
2.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
346
1507
12.72
79.77
18.5
6.2
e9/l
0.0
0.0
0.63
337
1327
(3001604) Monocytes [#/volume] in Blood
345
1503
12.45
79.34
18.6
6.2
e9/l
0.5
0.6
0.77
336
1322
(3013115) Eosinophils [#/volume] in Blood
350
1556
13.46
78.57
18.8
6.6
e9/l
0.2
0.2
0.04
340
1391
(3018418) pH of Serum or Plasma
236
728
6.70
78.29
6.4
3.6
ph
7.4
7.4
1.25
53
128
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
211
591
6.62
77.70
4.5
2.0
mg/l
3.3
3.0
0.70
192
511
(3019198) Lymphocytes [#/volume] in Blood
346
1567
11.93
74.50
18.6
6.1
e9/l
1.8
1.9
1.61
336
1403
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
60
36
19.52
73.53
1.4
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
253
896
6.22
69.87
6.4
2.4
u/l
70.5
56.6
1.48
244
842
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
298
1222
7.15
69.40
11.2
7.2
mmol/l
1.2
1.2
0.82
263
1064
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
280
1113
6.41
66.69
10.5
6.5
mmol/l
1.2
1.2
0.12
274
1030
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
79
91
10.64
65.31
5.4
4.6
mg/l
1.5
1.3
1.48
79
84
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
48
23
23.67
64.73
3.5
1.4
g/l
0.8
1.1
1.65
48
23
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
74
80
11.19
63.99
1.4
1.3
u/ml
378.1
188.3
2.24
41
46
(3017143) Hepatitis C virus Ab [Presence] in Serum
175
487
5.71
62.69
1.7
1.6
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
48
25
21.76
62.47
1.2
1.2
u/l
43.6
60.4
1.46
34
16
(3013650) Neutrophils [#/volume] in Blood by Automated count
351
1770
11.06
62.40
23.1
9.6
e9/l
3.5
4.1
7.89
345
1547
(3023183) Ammonium ion [Moles/volume] in Plasma
64
58
13.01
62.21
8.1
3.1
umol/l
33.7
35.9
0.26
57
47
(3016650) Hepatitis A virus Ab [Presence] in Serum
64
58
13.01
62.21
1.2
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
75
86
10.57
62.09
1.4
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
302
1373
6.36
58.71
25.5
8.3
e9/l
0.0
0.0
0.22
283
1125
(40758558) Short blood count panel - Blood
213
755
5.03
55.67
14.9
7.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
65
73
10.49
54.40
1.4
1.4
u/ml
127.1
91.5
—
7
14
(40768804) Tissue Pathology biopsy report
267
1144
5.25
54.38
3.7
1.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
65
76
10.07
52.76
1.4
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
84
139
7.43
50.97
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
189
645
4.75
50.97
1.8
1.6
—
—
—
0
0
(4035726)
103
211
6.28
50.67
1.8
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
73
104
8.41
50.55
1.7
1.6
iu/ml
0.0
0.0
0.42
28
17
(3013707) Erythrocyte sedimentation rate by Westergren method
371
2212
15.64
48.52
11.9
3.6
mm/h
15.1
9.2
11.59
365
2056
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
53
53
11.42
47.97
1.2
1.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
279
1318
4.95
47.92
4.5
2.6
ug/l
92.8
102.8
0.55
273
1235
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
51
49
11.83
47.40
2.8
4.6
u/ml
1393.7
3431.3
—
6
8
(3023368) Bacteria identified in Blood by Culture
186
657
4.51
47.26
8.4
4.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
185
653
4.50
47.01
3.9
2.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
33
16
22.44
43.91
2.1
1.3
u/l
4.5
2.4
—
21
5
(3048929) Epstein Barr virus Ab [Presence] in Serum
79
150
6.35
41.57
1.4
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
112
299
4.86
40.10
1.4
1.5
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
37
28
14.50
39.64
1.1
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
95
233
5.07
37.51
3.5
2.9
—
—
—
0
0
(4062490)
41
41
11.06
36.88
1.4
1.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
41
41
11.06
36.88
1.4
1.2
g/l
9.1
6.1
2.72
28
29
(3028192) IgG subclass 2 [Mass/volume] in Serum
41
41
11.06
36.88
1.4
1.2
g/l
3.4
2.4
2.35
27
29
(3024139) IgG subclass 3 [Mass/volume] in Serum
41
41
11.06
36.88
1.4
1.2
g/l
0.4
0.3
1.51
27
29
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
262
1336
3.94
36.66
6.6
3.9
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
37
36
11.25
33.85
1.2
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
362
2406
8.27
33.63
16.6
2.9
u/l
114.3
43.4
17.79
357
2303
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
27
16
18.06
32.68
3.2
4.3
mg/l
8.2
8.9
0.13
21
16
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
37
39
10.38
32.00
2.5
2.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
46
66
7.77
31.22
1.6
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
82
207
4.75
30.91
6.2
5.2
%
0.0
0.1
0.74
26
57
(3017181) Myelocytes/100 leukocytes in Blood
87
235
4.48
30.06
6.3
4.9
%
0.5
0.9
1.15
32
76
(3000991) Gas panel - Venous blood
83
217
4.59
29.89
16.4
10.0
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
82
215
4.57
29.40
5.6
4.9
%
0.3
0.5
0.72
25
56
(40768797) Stomach Pathology biopsy report
114
384
3.78
28.95
1.5
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
34
8
46.42
28.22
1.1
4.8
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
42
61
7.60
28.14
2.5
2.3
umol/l
31.6
4.8
3.76
37
44
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
49
85
6.45
27.85
1.3
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
80
217
4.38
27.34
6.7
5.2
%
0.0
0.2
1.27
30
66
(3018677) aPTT in Platelet poor plasma by Coagulation assay
111
382
3.67
27.13
3.3
2.7
s
30.5
29.8
0.59
111
374
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
88
264
4.02
26.19
3.1
4.3
u/l
203.6
237.3
2.60
88
251
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
77
213
4.26
25.56
3.1
2.4
ml/min/173m2
67.6
75.1
0.56
33
84
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
136
557
3.22
24.90
2.5
1.9
%
1.5
1.4
0.28
124
512
(3002582) Erythrocytes [#/volume] in Urine
174
827
3.00
24.44
4.1
2.8
e6/l
229.3
43.7
0.42
148
632
(3000850) Epithelial cells [#/volume] in Urine
133
547
3.18
24.07
3.4
2.3
e6/l
6.0
4.9
0.49
126
479
(3030467) Casts [#/volume] in Urine by Automated count
162
748
3.00
23.87
4.2
2.8
e6/l
0.3
0.3
0.10
137
553
(3025941) Bacteria identified in Stool by Culture
68
180
4.37
23.84
1.8
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
113
425
3.34
23.70
2.9
2.6
e6/l
2.2
2.1
0.07
76
228
(3044889) 12 lead EKG panel
311
2064
3.53
23.35
3.8
3.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
35
51
7.44
23.30
5.6
3.7
%
53.0
55.9
0.45
35
51
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
66
174
4.36
23.24
4.5
3.5
mmol/l
1.2
1.2
2.20
61
158
(3024932) HLA-DR beta [Type]
28
7
42.98
22.99
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
28
7
42.98
22.99
1.0
1.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
192
988
2.86
22.91
4.7
3.3
e6/l
46.6
96.2
0.48
153
676
(3023520) Reticulocytes [#/volume] in Blood
64
168
4.36
22.64
2.9
2.7
e9/l
77.3
75.9
0.07
46
124
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
27
30
9.60
22.33
1.0
1.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
75
224
3.91
22.25
6.9
4.3
mmol/l
0.7
1.8
2.03
67
176
(36304419) Bacteria [Presence] in Urine
157
736
2.90
22.19
4.2
2.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
45
90
5.52
21.97
1.7
2.3
g/l
1.1
1.5
1.80
40
80
(3026782) Osmolality of Urine
122
508
3.04
21.26
3.4
2.4
mosm/kgh2o
555.8
573.5
0.35
115
435
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
381
3190
10.45
21.13
49.1
11.1
mg/l
16.9
21.3
3.47
365
2421
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
103
403
3.12
19.87
2.5
1.8
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
182
967
2.66
19.63
4.2
2.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
50
121
4.59
19.52
16.7
16.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
151
742
2.69
18.93
11.0
4.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
109
454
2.95
18.71
3.1
2.5
e6/l
0.8
1.1
0.40
74
257
(3030905) Polymorphonuclear cells [#/volume] in Blood
31
51
6.52
18.40
5.9
3.3
e9/l
4.1
4.1
0.05
31
51
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
181
994
2.54
17.78
2.4
1.7
pmol/l
94.9
96.0
0.13
110
530
(44816559) Phosphatidylethanol [Mass/volume] in Blood
42
96
4.78
17.54
1.5
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
357
2768
4.52
17.39
50.6
13.9
%
13.7
13.4
3.92
357
2719
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
23
9
27.03
17.10
1.1
1.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
23
9
27.03
17.10
1.1
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
160
846
2.51
16.85
1.9
2.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
22
8
29.03
16.68
3.5
3.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
367
2961
5.23
15.55
39.1
9.9
ml/min/173m2
93.4
90.3
1.58
345
2399
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
32
65
5.27
15.27
2.9
5.5
u/ml
0.2
0.3
1.64
16
39
(3002256) Pathology report gross observation
86
349
2.88
15.21
1.3
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
47
133
3.88
14.85
1.8
1.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
72
269
3.06
14.74
12.9
14.2
inr
1.1
1.3
—
9
43
(3003694) ABO and Rh group [Type] in Blood
165
931
2.34
14.56
1.6
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
25
45
5.87
13.54
2.8
2.6
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
13
10
13.41
13.43
2.2
1.7
umol/l
1.7
1.8
—
13
10
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
100
473
2.50
12.87
1.9
1.6
pmol/l
475.5
436.9
0.52
87
421
(3014148) Varicella zoster virus Ab [Titer] in Serum
26
51
5.39
12.87
1.0
1.1
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
62
230
3.02
12.77
17.3
12.3
%
96.2
96.2
0.00
62
220
(3003327) Ova and parasites identified in Stool by Light microscopy
40
113
3.83
12.63
1.9
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
32
77
4.44
12.50
4.4
3.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
70
282
2.81
12.40
2.5
1.7
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
66
258
2.88
12.37
16.3
11.5
mmol/l
-0.3
1.2
2.37
56
204
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
70
285
2.78
12.15
2.5
1.8
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
58
217
2.97
11.74
17.1
11.9
g/l
117.7
125.2
1.61
58
206
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
20
35
5.97
11.12
1.3
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
136
778
2.15
10.98
1.5
1.2
u/ml
1.2
1.7
0.36
35
222
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
25
55
4.79
10.87
1.0
1.1
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
11
11
10.26
9.58
2.5
1.5
umol/l
26.5
28.6
0.16
11
11
(3012501) Base excess in Blood by calculation
22
49
4.70
9.42
3.6
2.3
mmol/l
2.0
2.9
0.99
14
34
(3019309) Folate [Moles/volume] in Red Blood Cells
79
383
2.33
9.40
2.1
1.6
nmol/l
1230.6
1147.4
0.28
63
304
(40761536) Microorganisms panel - Urine sediment
58
244
2.62
9.35
3.7
2.9
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
14
20
7.22
9.34
4.4
2.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
266
2015
2.01
9.24
5.1
3.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
123
722
2.03
8.98
4.6
2.5
umol/l
356.0
6923.9
3.07
117
650
(40767503) Oxygen content in Capillary blood by calculation
20
43
4.85
8.92
3.6
2.3
%
14.6
17.3
—
10
21
(3051611) Lipemic interference index of Serum or Plasma
16
28
5.92
8.87
4.1
2.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
26
71
3.85
8.60
2.5
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
362
3140
3.20
8.57
42.1
12.1
%
39.8
41.3
6.20
327
2583
(3004588) Protein electrophoresis panel - Serum or Plasma
37
128
3.09
8.54
1.8
2.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
12
6
20.57
8.52
1.0
1.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
345
2935
2.55
8.24
47.0
14.3
g/l
332.3
334.4
4.27
345
2920
(3000494) Fungus identified in Specimen by Culture
72
359
2.23
7.95
2.1
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
24
67
3.75
7.70
2.4
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
12
18
6.85
7.65
1.2
1.0
miu/ml
1212.2
1519.8
0.51
12
18
(3021601) Nitrite [Presence] in Urine by Test strip
200
1462
1.76
6.89
4.9
4.3
estimate
0.0
0.0
0.00
57
281
(3035350) Ketones [Presence] in Urine by Test strip
200
1464
1.75
6.84
3.7
3.0
estimate
0.0
0.0
0.00
55
273
(3009261) Glucose [Presence] in Urine by Test strip
202
1483
1.75
6.84
3.7
3.1
estimate
0.0
0.0
0.50
58
269
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
77
418
2.05
6.79
5.0
2.7
mmol/l
2.5
2.4
1.34
71
369
(4281824)
13
25
5.35
6.53
1.3
1.1
—
—
—
0
0
(3015736) pH of Urine
164
1146
1.75
6.52
3.1
2.9
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
10
7
14.62
6.43
3.5
1.3
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
13
26
5.14
6.27
2.2
1.3
pg
31.9
33.8
0.78
13
26
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
19
53
3.72
6.11
1.6
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
19
53
3.72
6.11
1.6
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
15
35
4.42
6.08
1.7
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
103
641
1.83
6.00
3.0
3.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
374
3419
3.43
5.81
33.5
10.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
18
53
3.51
5.37
2.2
3.7
mg/l
36.5
159.1
0.56
11
45
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
18
53
3.51
5.37
2.2
3.7
mg/l
30.0
29.4
0.04
11
44
(42529406) Shigella sp [Presence] in Stool by Culture
27
102
2.77
5.36
1.3
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
75
3.05
5.23
2.1
2.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
70
3.11
5.18
2.2
2.3
g/l
12.6
10.0
1.07
21
64
(3009871) Measles virus Ab [Titer] in Serum
8
6
13.57
5.10
1.8
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
50
3.51
5.08
2.6
1.8
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
19
5.38
5.06
1.6
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
20
66
3.14
5.02
1.4
1.4
ug/g
246.7
290.7
0.37
13
39
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
26
100
2.71
5.00
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
26
100
2.71
5.00
1.3
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
15
41
3.77
4.97
3.7
2.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
81
494
1.81
4.97
3.6
3.5
ng/l
19.1
285.0
2.65
58
340
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
46
3.58
4.94
1.8
1.6
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
12
28
4.39
4.86
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
12
28
4.39
4.86
1.2
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
14
37
3.89
4.85
2.1
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
14
37
3.89
4.85
2.1
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
14
37
3.89
4.85
2.1
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
14
37
3.89
4.85
2.1
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
14
37
3.89
4.85
2.1
1.5
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
27
108
2.61
4.82
1.2
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
296
2536
1.70
4.72
3.7
3.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
99
649
1.70
4.71
2.7
2.6
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
14
38
3.78
4.69
2.1
1.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
33
148
2.34
4.65
1.5
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
37
175
2.23
4.62
3.4
3.5
mmol/l
1.8
1.4
0.17
22
129
(3020393) Adenovirus Ag [Presence] in Stool
7
5
14.22
4.59
1.3
1.4
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
8
8
10.18
4.54
1.4
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
349
3152
2.04
4.51
6.4
3.9
mmol/l
4.6
4.7
1.72
342
2977
(3029937) Albumin [Presence] in Urine by Test strip
112
770
1.64
4.42
4.3
3.2
estimate
0.0
0.0
0.50
57
272
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
12
7.65
4.37
1.1
2.1
—
—
—
0
0
(3009343) pH of Capillary blood
37
181
2.15
4.26
3.5
3.5
ph
7.4
7.4
—
8
18
(3042111) Morphology [Interpretation] in Bone marrow Narrative
13
38
3.50
3.93
1.3
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
10
24
4.25
3.91
1.3
1.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
18
65
2.86
3.91
2.3
2.3
g/l
37.6
39.0
0.47
18
59
(40760888) Immunoglobulin light chains.free panel - Serum
13
39
3.41
3.79
1.2
4.3
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
7
8
8.88
3.78
5.0
2.9
%
47.9
52.3
—
7
8
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
133
989
1.52
3.64
3.7
3.1
ng/l
22.7
34.2
0.76
81
577
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
97
676
1.58
3.54
2.3
1.9
mg/l
1.8
0.9
1.34
81
502
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
13
6.26
3.51
1.3
1.2
ug/l
11.5
8.5
—
8
13
(3007930) Methemoglobin/Hemoglobin.total in Blood
21
88
2.47
3.45
5.0
11.2
%
0.9
0.9
0.02
21
80
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
9
18
5.09
3.39
2.3
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
7
10
7.10
3.37
1.3
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
17
65
2.69
3.35
1.9
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
24
109
2.28
3.33
1.1
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
33
172
2.00
3.25
1.2
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
17
67
2.61
3.17
1.9
1.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
21
92
2.36
3.16
4.8
10.7
%
1.3
1.6
0.60
21
83
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
8
16
5.08
3.06
1.1
1.0
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
12
40
3.06
2.99
1.7
1.5
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
5
5
10.11
2.98
1.2
1.2
umol/l
17.6
16.4
—
5
5
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
5
10.11
2.98
1.0
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
5
5
10.11
2.98
1.0
1.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
147
1156
1.44
2.92
3.9
3.0
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
7
13
5.46
2.88
1.7
2.1
%
206.9
131.7
—
7
13
(3004716) Salmonella sp identified in Stool by Organism specific culture
35
196
1.86
2.83
1.4
1.3
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
31
536
0.54
2.78
2.3
2.5
ug/l
0.9
0.7
0.30
17
289
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
14
5.07
2.74
4.9
3.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
14
5.07
2.74
1.1
1.0
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
9
24
3.81
2.69
2.0
2.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
7
15
4.73
2.61
1.1
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
11
38
2.95
2.60
2.0
1.6
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
7
7.22
2.55
2.0
2.0
u/l
16.8
14.6
—
5
7
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
11
5.52
2.55
1.7
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
8
21
3.87
2.47
1.3
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
13
51
2.60
2.47
1.1
1.2
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
0
63
0.00
2.45
0.0
6.5
—
376.1
—
0
55
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
10
34
2.99
2.43
1.6
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
112
864
1.42
2.41
3.7
2.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
12
5.06
2.41
2.0
1.5
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
12
5.06
2.41
2.2
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
9
28
3.27
2.32
1.8
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
17
79
2.20
2.28
1.8
2.5
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
7
18
3.94
2.26
1.3
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
18
3.94
2.26
1.9
3.3
u/ml
5662.0
765.6
—
7
18
(3045142) Bone marrow Pathology biopsy report
9
29
3.15
2.24
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
24
129
1.92
2.22
1.3
1.4
miu/ml
243.1
285.5
0.19
11
64
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
9
5.61
2.22
1.0
1.1
—
—
—
0
0
(3019225) pH of Specimen
37
228
1.69
2.21
5.0
4.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
109
850
1.39
2.18
3.3
3.0
mmol/l
8.6
8.6
0.06
101
739
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
50
2.44
2.04
1.5
1.7
—
—
—
0
0
(44790047)
9
32
2.85
2.01
2.2
1.7
—
—
—
0
0
(44790049)
9
32
2.85
2.01
2.2
1.7
—
—
—
0
0
(44790048)
9
32
2.85
2.01
2.2
1.7
—
—
—
0
0
(44806118)
9
32
2.85
2.01
2.2
1.7
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
51
721
0.66
2.01
2.6
3.6
%
20.1
21.8
0.28
13
265
(3007853) Bacteria identified in Skin by Aerobe culture
50
341
1.54
2.00
1.7
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
19
98
1.99
1.99
2.5
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
52
2.35
1.89
1.3
1.5
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
53
0.00
1.88
0.0
1.5
—
21.2
—
0
47
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
18
93
1.98
1.88
2.3
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
34
2.69
1.87
1.4
1.6
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
12
4.21
1.83
2.2
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
12
4.21
1.83
2.2
1.5
—
—
—
0
0
(3039000) Anion gap in Blood
12
53
2.30
1.82
5.2
15.8
mmol/l
12.3
11.3
0.51
12
45
(3018572) Chloride [Moles/volume] in Blood
12
53
2.30
1.82
5.2
15.8
mmol/l
106.6
105.4
0.44
12
45
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
23
3.08
1.80
3.7
2.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
87
676
1.37
1.76
3.3
3.3
mg/l
53.4
367.5
1.06
55
449
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
21
118
1.82
1.74
1.6
2.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
5
13
3.88
1.72
1.0
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
20
112
1.83
1.68
1.6
1.8
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
16
83
1.97
1.67
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
16
83
1.97
1.67
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
19
3.19
1.66
1.7
1.1
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
14
3.60
1.62
1.6
1.4
ug/l
89.4
69.7
—
5
14
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
10
43
2.36
1.61
2.4
2.7
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
90
714
1.34
1.59
4.3
4.0
mg/mmol
10.6
8.9
0.14
60
472
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
18
307
0.57
1.57
11.3
5.9
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
8
33
2.45
1.54
1.9
3.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
44
0.00
1.52
0.0
20.5
—
1389.5
—
0
44
(36660697) Celiac disease serology panel - Serum
39
269
1.50
1.51
1.2
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
113
1346
0.77
1.50
3.3
2.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
9
37
2.47
1.49
1.0
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
7
28
2.53
1.46
1.1
1.9
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
16
3.15
1.44
1.4
1.5
—
—
—
0
0
(4268621)
10
46
2.20
1.41
2.6
2.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
7
29
2.44
1.40
1.4
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
7
29
2.44
1.40
1.4
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
7
29
2.44
1.40
1.4
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
24
366
0.63
1.37
1.4
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
17
2.97
1.36
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
17
2.97
1.36
1.8
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
37
0.00
1.35
0.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
251
2303
1.25
1.33
4.1
3.7
pmol/l
14.4
14.6
0.44
239
2125
(3019230) Fractional oxyhemoglobin in Venous blood
9
44
2.07
1.27
8.3
2.1
%
58.4
65.7
—
9
44
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
73
583
1.31
1.24
2.3
3.2
ng/l
1348.8
698.7
0.70
66
474
(21494755) Public health laboratory ask at order entry panel
38
517
0.71
1.23
1.3
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
38
2.13
1.19
1.1
1.2
—
—
—
0
0
(3013512) EKG study
84
692
1.27
1.13
3.1
3.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
7
30
2.36
1.13
1.4
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
7
30
2.36
1.13
1.4
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
7
30
2.36
1.13
1.4
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
10
51
1.99
1.12
7.5
2.9
—
—
—
0
0
(3000492) Spirometry study
45
340
1.37
1.11
1.5
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
7
33
2.14
1.06
1.0
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
9
46
1.98
1.04
2.1
1.8
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
20
131
1.56
1.02
1.5
1.3
u/l
5.0
7.7
1.16
14
109
(3022313) Gas panel - Capillary blood
21
140
1.53
0.99
3.3
3.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
27
2.24
0.94
1.0
1.6
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
28
2.16
0.92
1.2
1.1
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
28
203
1.41
0.90
2.0
2.5
e9/l
4.1
4.1
0.02
20
175
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
57
1.77
0.84
1.2
1.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
43
339
1.30
0.83
1.7
2.3
nmol/l
15.9
14.4
0.59
38
318
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
294
2803
1.20
0.81
4.6
4.3
mu/l
1.9
2.2
0.32
280
2616
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
21
292
0.70
0.81
1.1
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
11
66
1.69
0.79
1.0
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
33
1.83
0.79
1.0
2.0
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
48
1.68
0.79
1.1
1.5
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
15
221
0.67
0.78
1.9
1.8
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
31
237
1.33
0.75
1.1
1.3
iu/ml
106.5
149.0
—
8
103
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
34
432
0.77
0.75
1.2
1.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
24
2.10
0.75
1.4
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
24
2.10
0.75
1.6
2.4
%
7.3
13.4
—
5
24
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
24
2.10
0.75
1.0
1.0
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
18
125
1.46
0.74
3.2
3.7
mmol/l
23.6
24.8
1.45
18
120
(3000764) Benzodiazepines [Presence] in Urine
20
275
0.71
0.73
2.1
1.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
325
3137
1.22
0.73
5.4
3.8
mmol/l
1.5
1.4
5.30
317
2952
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
110
0.54
0.73
1.5
2.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
21
151
1.41
0.73
7.9
8.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
39
1.81
0.73
1.0
1.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
39
1.81
0.73
1.0
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
316
3045
1.20
0.71
5.0
3.5
mmol/l
1.2
1.3
2.90
308
2861
(3008152) Bicarbonate [Moles/volume] in Arterial blood
20
144
1.41
0.69
14.8
11.5
mmol/l
23.3
24.5
0.75
20
132
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
5
27
1.86
0.68
6.8
3.8
—
24.8
—
0
8
(1002224) Polysomnography panel
13
189
0.68
0.65
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
21
279
0.74
0.64
2.0
1.9
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
13
87
1.51
0.64
1.2
1.2
—
3.1
—
0
10
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.2
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.2
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
29
1.73
0.64
2.0
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
29
1.73
0.64
1.2
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
21
278
0.74
0.63
2.0
1.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
328
3182
1.20
0.61
5.5
4.2
mmol/l
2.7
2.9
4.06
318
2988
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
0.0
—
0
8
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
20
0.00
0.60
0.0
1.3
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
21
0.00
0.60
0.0
9.0
—
53.8
—
0
9
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.1
—
1.1
—
0
13
(1617658) Protocol used for examination of sentinel lymph nodes
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
19
252
0.74
0.58
1.6
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
21
274
0.75
0.58
2.0
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
39
470
0.81
0.58
1.6
1.8
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
88
0.56
0.56
2.2
1.8
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
90
0.55
0.56
1.0
1.5
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
65
1.55
0.56
1.1
1.2
—
1.0
—
0
6
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
14
192
0.72
0.53
1.0
1.0
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
20
259
0.76
0.53
2.1
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
51
586
0.85
0.47
1.7
2.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
7
50
1.41
0.45
1.0
1.3
u/l
36.9
10.9
—
7
45
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
17
219
0.77
0.45
1.4
1.3
—
34.7
—
0
12
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
69
1.46
0.44
1.1
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
57
644
0.87
0.43
1.8
2.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
31
1.62
0.43
1.4
1.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
31
1.62
0.43
2.8
2.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
94
0.63
0.42
1.3
1.3
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
5
32
1.57
0.42
11.0
2.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
5
33
1.52
0.41
1.4
1.4
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
34
1.48
0.40
1.0
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
34
1.48
0.40
1.2
1.2
nmol/l
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
8
61
1.32
0.39
1.1
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
137
0.72
0.39
1.4
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
35
1.43
0.39
1.8
1.5
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
5
36
1.39
0.38
2.2
1.2
pmol/l
1017.0
420.5
—
5
30
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
77
0.64
0.36
1.6
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
9
124
0.72
0.35
2.0
2.2
—
—
—
0
0
(4306422)
7
54
1.30
0.30
1.1
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
7
56
1.25
0.29
1.4
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
18
216
0.83
0.29
1.5
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
9
117
0.76
0.28
1.4
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
9
117
0.76
0.28
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
9
118
0.76
0.28
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
9
118
0.76
0.28
1.4
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
104
1.26
0.26
1.2
1.4
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
8
67
1.20
0.26
1.0
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
127
0.78
0.26
1.6
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
27
306
0.87
0.24
1.7
2.1
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
38
1.32
0.23
1.0
1.2
—
—
—
0
0
(4034850)
12
97
1.24
0.23
9.8
7.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
39
1.29
0.23
1.2
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
7
92
0.76
0.22
1.4
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
7
95
0.73
0.22
1.4
1.6
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.4
—
75.9
—
0
11
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
12
0.00
0.21
0.0
2.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
24.4
—
0
12
(3000012) Reticulocyte production index
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
13
0.00
0.21
0.0
2.1
—
5.3
—
0
13
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
64
684
0.92
0.20
4.8
3.1
kg/l
1.0
1.0
—
8
85
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
6.7
—
0
14
(3014051) Protein [Presence] in Urine by Test strip
6
52
1.16
0.19
1.3
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
5
66
0.75
0.17
1.0
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
68
1.18
0.16
1.0
1.1
—
—
—
0
0
(4094501)
10
84
1.20
0.14
1.2
1.1
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
98
0.81
0.14
1.4
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
44
468
0.93
0.13
1.6
1.4
—
—
—
0
0
(4010399)
19
211
0.90
0.13
1.4
1.4
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
50
528
0.94
0.12
1.3
1.2
u/ml
1.3
9.4
3.39
17
214
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
295
2983
0.95
0.12
3.8
3.8
mmol/l
5.8
5.8
0.09
285
2775
(3001019) Free T4 and TSH panel - Serum or Plasma
23
210
1.10
0.12
1.3
1.7
—
—
—
0
0
(3020891) Body temperature
11
95
1.16
0.11
11.2
5.4
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
106
1.14
0.10
1.2
1.1
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
5
46
1.09
0.09
6.2
2.8
mmol/l
1.2
1.5
—
5
46
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
275
2777
0.97
0.09
6.1
4.7
mmol/mol
37.3
38.7
1.74
267
2631
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
6
54
1.11
0.09
1.0
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
66
1.06
0.08
1.3
1.1
—
11.5
—
0
7
(3049717) Cytology report of Urine Cyto stain
6
74
0.81
0.07
2.8
2.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
19
176
1.08
0.07
2.3
1.9
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
20
186
1.08
0.07
2.5
2.3
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
94
0.85
0.06
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
95
0.84
0.06
1.4
1.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
9
105
0.85
0.06
1.9
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
19
179
1.06
0.05
1.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
120
1.09
0.05
1.5
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
19
180
1.06
0.04
3.2
2.0
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
77
783
0.98
0.03
1.7
1.5
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
55
541
1.02
0.02
1.3
1.3
iu/ml
19.4
26.5
0.45
18
172
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
49
498
0.98
0.01
1.4
1.5
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
157
1.02
0.00
2.6
2.7
u/l
2364.3
3216.0
—
8
64
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
50
1.00
0.00
1.4
1.4
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
2.1
—
0
6
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
7.2
—
0
6
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
6
59
1.02
0.00
4.7
3.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
21
210
1.00
0.00
2.1
3.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
54
0.92
0.00
1.2
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
14.4
—
0
9
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
72
0.97
0.00
2.9
1.8
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.6
—
57.3
—
0
5
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
1.0
—
4.0
—
0
5
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(4015189)
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
7
0.00
0.00
0.0
3.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
11
110
1.00
0.00
3.6
3.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
5
0.00
0.00
0.0
2.6
—
74.8
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint K11_PSC_COLITIS_STRICT and mortality.
Females
No dataMales
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| K11_PSC_COLITIS_STRICT | 2.174 [1.71, 2.76] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 113 out of 793 males with K11_PSC_COLITIS_STRICT died.
Mortality risk
Mortality risk for people of age
years, who have K11_PSC_COLITIS_STRICT.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | 0.422% |
| 5 | No data | 2.357% |
| 10 | No data | 5.82% |
| 15 | No data | 11.196% |
| 20 | No data | 19.291% |
Relationships between endpoints
↥Index endpoint: K11_PSC_COLITIS_STRICT – Colitis, primary sclerosing, strict definition
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data